Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death
Article first published online: 27 MAR 2012
© 2012 John Wiley & Sons A/S
Pigment Cell & Melanoma Research
Volume 25, Issue 3, pages 354–369, May 2012
How to Cite
Brohem, C. A., Massaro, R. R., Tiago, M., Marinho, C. E., Jasiulionis, M. G., de Almeida, R. L., Rivelli, D. P., Albuquerque, R. C., de Oliveira, T. F., de Melo Loureiro, A. P., Okada, S., Soengas, M. S., de Moraes Barros, S. B. and Maria-Engler, S. S. (2012), Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death. Pigment Cell & Melanoma Research, 25: 354–369. doi: 10.1111/j.1755-148X.2012.00992.x
- Issue published online: 17 APR 2012
- Article first published online: 27 MAR 2012
- Accepted manuscript online: 28 FEB 2012 12:35PM EST
- PUBLICATION DATA Received 5 May 2011, revised and accepted for publication 17 February 2012, published online 28 February 2012
Figure S1. Fibroblasts are resistant to 4-NC action. Human dermal fibroblasts derived from foreskin (FF282, FF284, FF287 and HNF) were treated with 4-NC (10 and 30 μM) for 24 h.
Figure S2. Cell viability measured by Trypan Blue assay.
Figure S3. Evaluation of anti and proapoptotic factors levels in melanocytes, keratinocytes and melanomas at lower concentration of 4-NC.
Figure S4. Cell viability measured by MTT assay.
Figure S5. Effects of 4-NC on the dermal equivalent contraction (normal human fibroblasts (FHN) embedded in type I collagen gel).
|PCMR_992_sm_figs1.tiff||1520K||Supporting info item|
|PCMR_992_sm_figs2.tif||5545K||Supporting info item|
|PCMR_992_sm_figs3.tif||7375K||Supporting info item|
|PCMR_992_sm_figs4.tif||10199K||Supporting info item|
|PCMR_992_sm_figs5.tiff||348K||Supporting info item|
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.